Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories Ltd has filed a disclosure with BSE pursuant to Regulation 30 of the SEBI Listing Regulations, 2015. The specific subject matter of the disclosure is not clear from the truncated headline provided. Regulation 30 filings are used by listed companies to inform the stock exchanges about material events or developments that may impact the company or its shareholders. Without the full text, the exact nature of the announcement cannot be determined.
The impact on shareholders cannot be assessed without knowing the specific content of the disclosure. Investors should read the full filing on BSE to understand the material event being communicated.